Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

546
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
546
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

1.3K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.3K
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors01:13

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors

989
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
989
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

1.7K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
1.7K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

1.3K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.3K
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

900
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
900

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low Tidal Ventilation in Acute Respiratory Distress Syndrome: How Fragile Is Our Gold Standard?

Critical care medicine·2023
Same author

A pilot study on the utility of a more informative living will.

The West Virginia medical journal·2014
Same author

Patients don't consider end-stage medical conditions the same as being permanently unconscious when they fill out a living will.

The Journal of clinical ethics·2010
Same author

The Code Blue 2-min drill.

Resuscitation·2009
Same author

Visual hallucinations in a patient with adult onset acid maltase deficiency disorder.

Journal of general internal medicine·2009
Same author

Resident perceptions of work hour limitations: has the 80-hour work week doomed the 3-year Internal Medicine residency?

Journal of general internal medicine·2007

Related Experiment Video

Updated: Feb 17, 2026

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.6K

Stress ulcer prophylaxis.

Jack L DePriest

    Postgraduate Medicine
    |December 12, 2017
    PubMed
    Summary

    Critically ill patients face risks of gastrointestinal bleeding from stress ulcers. This review examines stress ulcer prophylaxis, evaluating agents that may reduce bleeding-related morbidity and mortality in intensive care units.

    Area of Science:

    • Critical care medicine
    • Gastroenterology
    • Pharmacology

    Background:

    • Critically ill patients in intensive care units (ICUs) are susceptible to gastrointestinal (GI) bleeding.
    • Stress ulcers are a common complication in these patients, potentially leading to significant morbidity and mortality.
    • Identifying patients at high risk is crucial for timely intervention.

    Purpose of the Study:

    • To identify critically ill patients at increased risk for gastrointestinal hemorrhage due to stress ulcers.
    • To evaluate the efficacy of prophylactic agents in reducing morbidity and mortality associated with stress-related GI hemorrhage.
    • To review the current literature on stress ulcer prophylaxis, outlining risks and benefits.

    Main Methods:

    • Literature review of recent studies on stress ulcer prophylaxis.

    More Related Videos

    Author Spotlight: Point-of-Care Ultrasound for Gastric Content Assessment and Risk Stratification in Perioperative Care
    05:50

    Author Spotlight: Point-of-Care Ultrasound for Gastric Content Assessment and Risk Stratification in Perioperative Care

    Published on: September 22, 2023

    4.5K
    Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
    05:23

    Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

    Published on: March 7, 2025

    852

    Related Experiment Videos

    Last Updated: Feb 17, 2026

    Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
    03:05

    Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

    Published on: February 16, 2024

    1.6K
    Author Spotlight: Point-of-Care Ultrasound for Gastric Content Assessment and Risk Stratification in Perioperative Care
    05:50

    Author Spotlight: Point-of-Care Ultrasound for Gastric Content Assessment and Risk Stratification in Perioperative Care

    Published on: September 22, 2023

    4.5K
    Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
    05:23

    Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

    Published on: March 7, 2025

    852
  • Analysis of risk factors for gastrointestinal hemorrhage in critically ill patients.
  • Assessment of the effectiveness of various prophylactic agents.

    • Main Results:

    • The review identifies specific patient populations at higher risk for stress ulceration and subsequent bleeding.
    • Prophylactic agents demonstrate varying degrees of efficacy in preventing stress-related GI bleeding.
    • The benefits of prophylaxis must be weighed against potential risks and side effects.

    Conclusions:

    • Risk stratification is essential for appropriate prophylactic therapy selection in critically ill patients.
    • Prophylactic agents can reduce the incidence of stress ulcer-related gastrointestinal hemorrhage.
    • A balanced approach considering patient-specific factors and agent profiles is recommended for optimal outcomes.